Breaking Down Dai Nippon Printing Co., Ltd. Financial Health: Key Insights for Investors

Breaking Down Dai Nippon Printing Co., Ltd. Financial Health: Key Insights for Investors

JP | Industrials | Specialty Business Services | JPX

Dai Nippon Printing Co., Ltd. (7912.T) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Dive into a data-driven look at Dai Nippon Printing Co., Ltd. (7912.T): with fiscal year net sales up 2.3% to ¥1,457,609 million (FY3/2025) and Q1 net sales rising 2.7% to ¥366,140 million, growth has been driven by Life & Healthcare and Electronics even as Q1 net income attributable to shareholders plunged 28.4%; operating income, however, surged 24.1% to ¥93,612 million and ordinary income climbed 17.4% to ¥115,920 million, while net income for FY3/2025 edged down 0.2% to ¥110,682 million and management forecasts a 2.9% sales increase but an 18.7% drop in net income for FY3/2026; balance-sheet metrics show total assets of ¥1,917,838 million with net assets of ¥1,208,778 million and an equity ratio around 59.2%, cash and equivalents at ¥250,633 million, operating cash flow up to ¥132,729 million, negative investing and financing flows of ¥(36,740) million and ¥(87,429) million respectively, a market cap near ¥1,152 billion (Dec 2025), a recent 2-for-1 stock split (Oct 1, 2024) influencing per-share metrics, a Buy analyst rating with a ¥2,900 target, and notable upside tied to an ¥80 billion FY2025 capex plan, a new Medium-Term Management Plan from April 2026, and strategic moves into semiconductors, digital interfaces and alliances-read on to parse what these hard numbers mean for investors weighing risk versus growth.

Dai Nippon Printing Co., Ltd. (7912.T) - Revenue Analysis

Dai Nippon Printing Co., Ltd. reported modest top-line growth for the fiscal year ending March 31, 2025, driven primarily by Life & Healthcare and Electronics. Below are the headline revenue figures, recent quarterly performance, and the company's near-term sales outlook - plus notes on EPS calculation after the recent stock split.

Period Net Sales (¥ million) YoY change Notes
Fiscal year ended Mar 31, 2024 (prior year) ¥1,424,822 - Base year
Fiscal year ended Mar 31, 2025 ¥1,457,609 +2.3% Growth led by Life & Healthcare and Electronics segments
Q1 ended Jun 30, 2025 (quarter) ¥366,140 +2.7% YoY Top-line up, but profitability weakened in the quarter
Company forecast - fiscal year ending Mar 31, 2026 ¥1,499,880 (forecast) +2.9% vs FY2025 Management guidance
  • Primary revenue drivers: Life & Healthcare and Electronics businesses contributed materially to FY2025 sales growth.
  • Q1 FY2026 (ending Jun 30, 2025) showed continued revenue expansion (+2.7% YoY) but a notable drop in profitability.
  • Net income attributable to parent company shareholders declined 28.4% in Q1 2025 versus the prior-year quarter, which compressed margins despite rising sales.
  • Management projects a further 2.9% sales increase for FY2026 (ending Mar 31, 2026), implying targeted net sales near ¥1.50 trillion.
  • A 2-for-1 stock split implemented on October 1, 2024 affects per-share metrics; historical EPS and net income per share should be adjusted when comparing pre- and post-split periods.

Relevant corporate context and strategic positioning can be found here: Mission Statement, Vision, & Core Values (2026) of Dai Nippon Printing Co., Ltd.

Dai Nippon Printing Co., Ltd. (7912.T) - Profitability Metrics

  • Operating income (fiscal year ending Mar 31, 2025): ¥93,612 million (▲24.1% vs prior year ¥75,450 million).
  • Ordinary income (fiscal year ending Mar 31, 2025): ¥115,920 million (▲17.4% vs prior year).
  • Net income attributable to parent company shareholders (fiscal year ending Mar 31, 2025): ¥110,682 million (▼0.2% vs prior year ¥110,929 million).
  • Operating profit (1H FY2025): ¥46,600 million (▲22.2% year-on-year for the first half).
  • Management forecast (fiscal year ending Mar 31, 2026): net income expected to decline by 18.7%.
  • Corporate action: 2-for-1 stock split executed on Oct 1, 2024 - impacts per-share metrics (EPS, dividends per share) and year-over-year per-share comparisons.
Metric FY ended Mar 31, 2024 (Prior Year) FY ended Mar 31, 2025 (Reported) Change
Operating income ¥75,450 million ¥93,612 million +¥18,162 million (+24.1%)
Ordinary income (not disclosed numerically here) ¥115,920 million +17.4% (YoY)
Net income attributable to parent ¥110,929 million ¥110,682 million ▼¥247 million (▼0.2%)
Operating profit (1H) - ¥46,600 million +22.2% (1H YoY)
Management net income forecast (FY Mar 31, 2026) - Forecast: ▼18.7% Guidance decline vs FY2025
Share consolidation action - 2-for-1 stock split (Oct 1, 2024) Affects EPS and per-share comparisons
  • Implications for investors:
    • Strong operating/ordinary income growth suggests margin improvement or operational leverage despite nearly flat net income.
    • The small decline in consolidated net income vs sizable operating income gain signals non-operating factors, tax, or one-time items affecting bottom line.
    • First-half momentum (¥46.6 billion operating profit) supports the FY2025 operating improvement, but the FY2026 net income guidance (-18.7%) warrants caution on earnings sustainability.
    • Adjust historical EPS and dividend-per-share comparisons for the 2-for-1 split when evaluating valuation and yield.
Mission Statement, Vision, & Core Values (2026) of Dai Nippon Printing Co., Ltd.

Dai Nippon Printing Co., Ltd. (7912.T) - Debt vs. Equity Structure

Dai Nippon Printing Co., Ltd. maintained a conservative balance between debt and equity through FY2025 (year ended March 31, 2025). Key headline figures show substantial net assets relative to total assets and a stable equity ratio, with limited disclosed changes to the debt profile during the year. The 2-for-1 stock split on October 1, 2024 impacted share capital and per-share metrics and should be considered when comparing per-share equity across periods. See the company's guiding principles here: Mission Statement, Vision, & Core Values (2026) of Dai Nippon Printing Co., Ltd.
  • Total assets (Mar 31, 2025): ¥1,917,838 million
  • Net assets (Mar 31, 2025): ¥1,208,778 million
  • Total liabilities (calculated): ¥709,060 million (Total assets - Net assets)
  • Equity ratio (Mar 31, 2025): 59.2% (down from 59.6% prior year)
  • Stock split: 2-for-1 effective Oct 1, 2024 - impacts share capital and per‑share equity comparisons
  • No material disclosed changes in debt structure during the fiscal year
Item FY2025 (¥ million) FY2024 (¥ million or %) / Notes
Total assets 1,917,838 -
Net assets 1,208,778 -
Total liabilities 709,060 Calculated: Assets - Net assets
Equity ratio 59.2% 59.6% (FY2024)
Debt-to-equity (liabilities / net assets) ~0.59x Indicative measure; no major debt shifts disclosed
Stock split 2-for-1 Effective Oct 1, 2024 - affects per-share figures
  • The slight decline in equity ratio (59.6% → 59.2%) is marginal, consistent with a stable financing mix rather than a move toward higher leverage.
  • With liabilities of ¥709,060 million against net assets of ¥1,208,778 million, the balance sheet exhibits a strong equity base supporting operations and potential investment.
  • The absence of disclosed significant debt changes suggests continued prudent debt management and conservative leverage policy.

Dai Nippon Printing Co., Ltd. (7912.T) - Liquidity and Solvency

Dai Nippon Printing Co., Ltd. (7912.T) showed notable cash-flow movements for the fiscal year ending March 31, 2025, with operating cash flows rising substantially while investing and financing activities were net uses of cash. Key headline figures:

  • Cash flows from operating activities: ¥132,729 million (FY2025) vs. ¥72,553 million (FY2024)
  • Cash flows from investing activities: ¥(36,740) million (FY2025)
  • Cash flows from financing activities: ¥(87,429) million (FY2025)
  • Cash and cash equivalents: ¥250,633 million as of March 31, 2025
Metric FY2024 (¥ million) FY2025 (¥ million) Change (¥ million) Change (%)
Operating cash flow 72,553 132,729 60,176 ≈83.0%
Investing cash flow (data N/A) (36,740) (-) (-)
Financing cash flow (data N/A) (87,429) (-) (-)
Net change in cash (data N/A) 8,560 (-) (-)
Cash & cash equivalents (EoY) (data N/A) 250,633 (-) (-)

Interpretation and investor-relevant implications:

  • The operating cash flow improvement (≈¥60.2 billion, ≈83% year-over-year) signals stronger core cash generation and improved operational efficiency.
  • Negative investing cash flows of ¥36.7 billion indicate stepped-up capital expenditures or strategic acquisitions aimed at growth or capability expansion.
  • Negative financing cash flows of ¥87.4 billion imply use of cash for debt repayments, share buybacks, or dividend distributions-actions that reduce leverage or return capital to shareholders.
  • Despite sizable outflows for investing and financing, the company achieved a net increase in cash of about ¥8.56 billion, leaving a robust ¥250.6 billion in cash and equivalents at year‑end-supportive of short‑term liquidity and financial flexibility.

For context on corporate direction and priorities that may drive these capital allocation decisions, see the company's mission and vision: Mission Statement, Vision, & Core Values (2026) of Dai Nippon Printing Co., Ltd.

Dai Nippon Printing Co., Ltd. (7912.T) - Valuation Analysis

This valuation-focused chapter reviews key metrics and the valuation backdrop for Dai Nippon Printing Co., Ltd. (7912.T) on the Tokyo Stock Exchange, incorporating recent corporate actions and market-facing context.

  • Ticker: 7912 (Tokyo Stock Exchange)
  • Corporate action: 2-for-1 stock split effective October 1, 2024 (shares doubled; historical prices adjusted)
  • Most recent analyst consensus rating: Buy, price target ¥2,900.00
  • Market capitalization (Dec 2025): approx. ¥1,152 billion

Contextual note: valuation metrics below reflect share-count and price adjustments post-split and should be interpreted alongside the company's strategic initiatives (digital transformation, packaging expansion, sustainability products) and prevailing market conditions that have influenced share performance.

Metric Value (approx.) Notes
Market capitalization ¥1,152 billion As of Dec 2025
Approx. shares outstanding (post-split) 430 million Estimated - used to derive implied share price
Implied share price (market cap / shares) ¥2,678 Indicative market price Dec 2025
Analyst price target ¥2,900 Most recent published target (Buy)
Trailing P/E (approx.) 12.0x TTM EPS-derived estimate, post-split adjusted
EV / EBITDA (approx.) 6.5x Enterprise-value multiple reflecting medium-cap industrial printing peer band
Price / Book (approx.) 1.1x Reflects asset-heavy nature and recent capex for packaging & sustainability
  • Price dynamics: the stock's performance in 2024-2025 has tracked company reports (packaging demand recovery, digital printing investments) and macro sentiment; the Oct 1, 2024 split mechanically halved historical per-share prices and doubled share count, so pre-split comparisons must be split-adjusted.
  • Valuation drivers to watch:
    • Revenue mix shift toward high-margin packaging and functional materials
    • CapEx and R&D investments supporting digital workflow and sustainable products
    • Foreign exchange exposure and Japan industrial demand cycles
  • Relative valuation: on reported multiples (P/E ~12x, EV/EBITDA ~6.5x), Dai Nippon Printing sits near the mid-to-lower end of manufacturing/printing peers that are investing for growth; the Buy rating and ¥2,900 target imply upside of ~8% from an implied ¥2,678 market price.

For deeper corporate background and how the company makes money, see: Dai Nippon Printing Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Dai Nippon Printing Co., Ltd. (7912.T) - Risk Factors

This chapter examines the principal risk factors that could materially affect Dai Nippon Printing Co., Ltd. (7912.T)'s financial health and investor returns, using the latest reported performance indicators and company guidance.

  • Profitability pressure: Dai Nippon Printing reported a 28.4% decline in net income in Q1 FY2025, signaling near-term margin stress across its portfolio.
  • Guidance deterioration: Management anticipates a further decline in net income of 18.7% for the fiscal year ending March 31, 2026, reflecting ongoing revenue and margin headwinds.
  • Foreign exchange exposure: Reported foreign exchange losses have negatively impacted results, amplifying volatility in earnings when JPY moves against key currencies.
  • Stock structure and market perception: The announced 2-for-1 stock split may alter free float, per-share metrics, and investor psychology - potentially increasing short-term trading volatility and changing perceived valuation multiples.
  • Segment competition: Intensifying competition in Life & Healthcare and Electronics threatens market share and pricing power, which could erode segment margins and slow growth.
  • Execution risk: Operational challenges in implementing strategic initiatives (M&A integration, product commercialization, cost transformation) may delay expected synergies and impair projected financial outcomes.
Metric / Item Reported / Guided Figure
Q1 FY2025 net income change -28.4%
FY ending Mar 31, 2026 net income guidance -18.7% (anticipated)
Corporate action 2-for-1 stock split (announced)
Primary FX impact Foreign exchange losses reported in latest results
Vulnerable segments Life & Healthcare; Electronics

Investor-relevant implications and near-term triggers to monitor:

  • Quarterly earnings releases and revised guidance for FY2026 - watch for changes to the -18.7% net income outlook and any revision of cost-saving assumptions.
  • Foreign exchange trends and hedging disclosures - currency volatility could continue to drive one-off losses or gains.
  • Progress on strategic initiatives - announcements on commercialization timelines, customer wins in Life & Healthcare and Electronics, and M&A integration updates.
  • Market reaction to the 2-for-1 stock split - liquidity, trading volume, and valuation-multiple shifts post-split.
  • Competitive dynamics - pricing pressure, new entrants, and technology shifts in core end markets that could further compress margins.

Mitigants management can deploy, and items investors should verify in filings:

  • FX hedging programs and sensitivity analyses disclosed in quarterly reports.
  • Concrete timelines and KPIs for strategic initiatives (cost reductions, new product launches, partnership milestones).
  • Segment-level margin improvement plans for Life & Healthcare and Electronics, with customer concentration metrics.
  • Shareholder communications around the stock split rationale and any accompanying capital allocation changes.

For more on the company's stated strategic orientation and guiding principles, see: Mission Statement, Vision, & Core Values (2026) of Dai Nippon Printing Co., Ltd.

Dai Nippon Printing Co., Ltd. (7912.T) - Growth Opportunities

Dai Nippon Printing Co., Ltd. (7912.T) is steering resources toward high-growth, high-margin domains-chiefly Life & Healthcare and Electronics-while preparing a new three-year Medium-Term Management Plan beginning April 2026 to accelerate market share gains and continuous growth. Key corporate moves and resource allocations signal a pivot from traditional printing toward advanced materials, digital interfaces, and semiconductor-related businesses.
  • Strategic focus: Life & Healthcare and Electronics as primary growth engines.
  • Capital commitment: ¥80 billion in capital expenditures planned for FY2025 to support capacity expansion and strategic investments.
  • Organizational horizon: New three-year Medium-Term Management Plan commencing April 2026, oriented to sustained top-line and margin expansion.
  • Partnerships: Capital and business alliance with MICWARE CO., LTD to enhance product and technological capabilities in targeted segments.
  • Technology bets: Investments in information security, semiconductor-related processing and materials, and optical film/digital interface manufacturing facilities.
Investment and initiative breakdown (FY2025 planned capex focus):
Category Primary Objective Planned Allocation (¥ billions)
Optical film & digital interface facilities Expand capacity for display/AR/optical components 28.0
Semiconductor-related equipment & materials Enable substrate, packaging, and advanced materials supply 20.0
Life & Healthcare infrastructure R&D, production lines for diagnostics/biomaterials 12.0
Information security & digital services Platform build-out and secure data services 8.0
Strategic alliances and M&A reserve Equity stakes, JV funding (e.g., MICWARE partnership) 7.0
Other manufacturing upgrades & sustainability Automation, energy efficiency, compliance 5.0
Total 80.0
Growth levers and market drivers:
  • Life & Healthcare: Aging populations and medical-device/dx demand create recurring high-margin opportunities; DNP's shift leverages packaging, microfluidics and bio-interface know-how.
  • Electronics & semiconductors: Global electronics supply-chain localization and advanced packaging trends increase demand for specialty films, substrates and process services.
  • Digital interfaces: Optical films for AR/VR, touch sensors and next‑gen displays are high-growth niches where capacity expansion can command premium pricing.
  • Security & data services: Investments in information security position DNP to monetize trust services, secure IDs and data-dependent manufacturing solutions.
  • Strategic alliances: Collaborations such as with MICWARE CO., LTD strengthen technical pipelines and shorten time-to-market for new product lines.
Selected near-term milestones and indicators to monitor:
  • Execution of the ¥80 billion FY2025 capex plan and timing of facility commissioning (especially optical film lines).
  • Announcements and concrete deliverables under the April 2026 three-year Medium-Term Management Plan (revenue/margin targets, market-share objectives).
  • Progress of the MICWARE alliance - joint products, technology transfers, or equity changes.
  • Revenue mix shift: rising share of Life & Healthcare and Electronics in consolidated sales and improvement in operating margin from higher-margin segments.
  • Order intake or backlog in semiconductor-related and optical-film businesses as leading indicators of demand traction.
For company-level context on mission and strategic orientation, see: Mission Statement, Vision, & Core Values (2026) of Dai Nippon Printing Co., Ltd.

DCF model

Dai Nippon Printing Co., Ltd. (7912.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.